PatientsVille.com Logo

PatientsVille

Delursan Side Effects

Report Delursan Side Effects

If you experienced any harmful or unwanted effects of Delursan, please share your experience. This could help to raise awareness about Delursan side effects, identify uknown risks and inform health professionals and patients taking Delursan.

Examples: headache, dizziness


The most commonly reported Delursan side effects are:
None (2 reports)

If you have experienced a side effect listed above, you can check a box to report it.


To view a complete list of submitted side effects, please follow the link Delursan side effects . You can also compare Delursan side effects or view FDA reports.

Delursan Side Effects reported to FDA

The following Delursan reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Delursan on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Toxic Epidermal Necrolysis, Bladder Disorder, Haematuria, Graft Versus Host Disease In Intestine, Renal Failure Acute, Hepatitis Fulminant, Oedema
on Nov 01, 2013 Female from FR , 41 years of age, was treated with Delursan (ursodeoxycholic Acid) Tablet. Directly after, patient experienced the unwanted or unexpected Delursan side effects: toxic epidermal necrolysis, bladder disorder, haematuria, graft versus host disease in intestine, renal failure acute, hepatitis fulminant, oedema. Delursan (ursodeoxycholic Acid) Tablet dosage: 3 Df, Bid, Oral.
Associated medications used:
  • Fortum (1 Df, Qid, Intravenous)
  • Flagyl
  • Gentamicine
  • Ambisome
  • Bactrim (2 Df, 3x/weekly, Itravenous)
  • Noxafil
  • Cancidas
  • Folinic Acid (50mg, 3x/wk, Intravenous)
Patient was hospitalized.

Abnormal Behaviour, Rash Pruritic, Dry Skin, Miliaria, Transient Global Amnesia, Skin Lesion
Patient was taking Delursan. Patient felt the following Delursan side effects: abnormal behaviour, rash pruritic, dry skin, miliaria, transient global amnesia, skin lesion on Jan 16, 2014 from FR Additional patient health information: Female , 63 years of age, weighting 121.3 lb, was diagnosed with and. Delursan dosage: N/A.

Rash Maculo-papular, Burning Sensation, Eczema, Eosinophilia, Leukocytosis, Hypoalbuminaemia, Oedema Peripheral
Adverse event was reported on Apr 22, 2013 by a Female taking Delursan (ursodeoxycholic Acid) Tablet (Dosage: N/A) was diagnosed with and. Location: FR , 57 years of age, After Delursan was administered, patient encountered several Delursan side effects: rash maculo-papular, burning sensation, eczema, eosinophilia, leukocytosis, hypoalbuminaemia, oedema peripheral. Patient was hospitalized.

Pancreatic Cyst, Weight Decreased, Hepatic Steatosis
on Feb 04, 2013 Male from FR , 50 years of age, was diagnosed with and was treated with Delursan. Directly after, patient experienced the unwanted or unexpected Delursan side effects: pancreatic cyst, weight decreased, hepatic steatosis. Delursan dosage: 5 Df, Qd, Oral.
Associated medications used:


Porphyria Non-acute
on Jun 11, 2012 Female from FRANCE , 48 years of age, was treated with Delursan. Patient felt the following Delursan side effects: porphyria non-acute. Delursan dosage: N/A.
Multiple prescriptions taken:

Synovitis, Soft Tissue Disorder, Arthralgia
Patient was taking Delursan. After Delursan was administered, patient encountered several Delursan side effects: synovitis, soft tissue disorder, arthralgia on Mar 16, 2012 from FRANCE Additional patient health information: Female , 55 years of age, was diagnosed with and. Delursan dosage: N/A.
Multiple concurrent drugs taken:
  • Irbesartan
  • Propranolol
  • Zoledronoc Acid (Unk Ukn, Unk)
  • Vitamin D
  • Calcium Carbonate


Synovitis, Arthralgia, Soft Tissue Disorder
Adverse event was reported on Mar 14, 2012 by a Female taking Delursan (Dosage: N/A) was diagnosed with and. Location: FRANCE , 55 years of age, Directly after, patient experienced the unwanted or unexpected Delursan side effects: synovitis, arthralgia, soft tissue disorder.
Associated medications used:

Cytolytic Hepatitis
on Nov 28, 2011 Female from FRANCE , weighting 131.6 lb, was treated with Delursan. Patient felt the following Delursan side effects: cytolytic hepatitis. Delursan dosage: 500 Mg, Bid.
Multiple prescriptions taken:
  • Cyclophosphamide (490 Mg, Qd)
  • Thymoglobulin (225 Mg, Qd)
  • Polaramine (10 Mg, Unk)
  • Solu-medrol (20 Mg, Tid)
  • Thymoglobulin (147.5 Mg, Once)
  • Thymoglobulin (3.5 Mg/kg, Qd)
  • Fludarabine Phosphate (49 Mg, Qd)
  • Sodium Bicarbonate (100 Ml, Qid)


Cytolytic Hepatitis
on Nov 14, 2011 Male from FRANCE , 58 years of age, weighting 156.5 lb, was treated with Delursan. After Delursan was administered, patient encountered several Delursan side effects: cytolytic hepatitis. Delursan dosage: N/A.
Multiple concurrent drugs taken:
  • Busulfan
  • Valium
  • Fludara
  • Pantoprazole
  • Fludara
  • Solu-medrol
  • Multi-vitamins
  • Zofran


Cytolytic Hepatitis
Patient was taking Delursan. Directly after, patient experienced the unwanted or unexpected Delursan side effects: cytolytic hepatitis on Nov 14, 2011 from FRANCE Additional patient health information: Female , weighting 131.6 lb, . Delursan dosage: 500 Mg, Bid.
Associated medications used:
  • Solu-medrol (20 Mg, Tid)
  • Thymoglobulin (147.5 Mg, Once)
  • Polaramine (10 Mg, Unk)
  • Fludarabine Phosphate (49 Mg, Qd)
  • Thymoglobulin (3.5 Mg/kg, Qd)
  • Cyclophosphamide (490 Mg, Qd)
  • Sodium Bicarbonate (100 Ml, Qid)


Hypoglycaemia, Coma
Adverse event was reported on Oct 20, 2011 by a Female taking Delursan (Dosage: N/A) . Location: FRANCE , 53 years of age, Patient felt the following Delursan side effects: hypoglycaemia, coma.
Multiple prescriptions taken:
  • Voltaren
  • Aldalix
  • Aspirin
  • Stablon
  • Noctamid
  • Panos
  • Propranolol (160 Mg, 1x/day)
  • Atarax
Patient was hospitalized.

Liver Transplant Rejection
on Jun 17, 2011 Male from FRANCE , weighting 149.9 lb, was diagnosed with and was treated with Delursan. After Delursan was administered, patient encountered several Delursan side effects: liver transplant rejection. Delursan dosage: N/A.
Multiple concurrent drugs taken:
  • Flodil Lp
  • Cyclosporine
  • Bipreterax
  • Neoral
  • Ribavirin
  • Cellcept
  • Peginterferon Alfa-2a


Cholestasis, Antimitochondrial Antibody Positive, Portal Hypertension, Biliary Cirrhosis Primary, Treatment Failure, Disease Progression
on Mar 04, 2011 Female from FRANCE , 70 years of age, weighting 143.3 lb, was diagnosed with and was treated with Delursan (ursodeoxycholic Acid) Tablet. Directly after, patient experienced the unwanted or unexpected Delursan side effects: cholestasis, antimitochondrial antibody positive, portal hypertension, biliary cirrhosis primary, treatment failure, disease progression. Delursan (ursodeoxycholic Acid) Tablet dosage: 500 Mg, Bid, Oral.

Toxic Skin Eruption
Patient was taking Delursan (ursodeoxychloic Acid) 250mg Tablet. Patient felt the following Delursan side effects: toxic skin eruption on Jul 22, 2010 from FRANCE Additional patient health information: Female , 80 years of age, . Delursan (ursodeoxychloic Acid) 250mg Tablet dosage: 250 Mg Tid Oral.
Multiple prescriptions taken:
  • Mysoline (250mg Bid Oral)
  • Hept A Myl (heptaminol) Tablet (187.8mg Qid Oral)
  • Stresam (etifoxine Hydrochloride)
  • Vastarel (trimetazidine) Tablet (35mg Bid Oral)
  • Calcium Carbonate
  • Fosavance (alendronic Acid, Colecalciferol)
Patient was hospitalized.

Transient Ischaemic Attack
Adverse event was reported on Nov 05, 2009 by a Male taking Delursan Tablets 250mg (ursodesoxycholic Acid) (Dosage: 250 Mg Oral) . Location: FRANCE , 47 years of age, After Delursan was administered, patient encountered several Delursan side effects: transient ischaemic attack.
Multiple concurrent drugs taken:
  • Xagrid (anagrelide) (2 Mg (0.5 Mg 4 Times A Day) Oral)
  • Previscan (fluindione) (15 Mg Oral)
  • Nexium (Oral)
  • Avlocardyl L.p. Prolonged Release Capsule (160 Mg Oral)
  • Acetaminophen (Oral)
  • Tardyferon (folic Acid) (Twice A Day Oral)
Patient was hospitalized.

Alanine Aminotransferase Increased, Anaemia Macrocytic, Anti-hbs Antibody Positive, Aspartate Aminotransferase Increased, C-reactive Protein Increased, Coagulation Factor Decreased, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased, Inflammation
on Dec 10, 2008 Female from FRANCE , 20 years of age, was diagnosed with and was treated with Delursan (ursodesoxycholic Acid). Directly after, patient experienced the unwanted or unexpected Delursan side effects: alanine aminotransferase increased, anaemia macrocytic, anti-hbs antibody positive, aspartate aminotransferase increased, c-reactive protein increased, coagulation factor decreased, gamma-glutamyltransferase increased, hepatic enzyme increased, inflammation. Delursan (ursodesoxycholic Acid) dosage: 500 Mg.
Associated medications used: Patient was hospitalized.

Amenorrhoea, Angiotensin Converting Enzyme Increased, Blood Alkaline Phosphatase Increased, Blood Creatinine Decreased, Disseminated Intravascular Coagulation, Gamma-glutamyltransferase Increased, Haemoglobin Decreased, Hepatosplenomegaly, Hyperproteinaemia
on Jun 26, 2008 Female from FRANCE , 56 years of age, was diagnosed with and was treated with Delursan (ursodeoxycholic Acid). Patient felt the following Delursan side effects: amenorrhoea, angiotensin converting enzyme increased, blood alkaline phosphatase increased, blood creatinine decreased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, haemoglobin decreased, hepatosplenomegaly, hyperproteinaemia. Delursan (ursodeoxycholic Acid) dosage: 500 Mg (delursan) Oral. Patient was hospitalized.

Haematuria, Thrombocytopenia
Patient was taking Delursan (ursodeoxycholic Acid). After Delursan was administered, patient encountered several Delursan side effects: haematuria, thrombocytopenia on Apr 22, 2008 from FRANCE Additional patient health information: Female , 85 years of age, . Delursan (ursodeoxycholic Acid) dosage: N/A.
Multiple concurrent drugs taken:
  • Pantoprazole Sodium (Po)
  • Stablon (tianeptine) Tablets 12.5 Mg (1 Df, 2 Days Po)
  • Actonel
  • Calcidose (calcium Carbonate)
  • Potassium Chloride
  • Furosemide
  • Solupred (prednisolone)
  • Amiodarone Hcl
Patient was hospitalized.

Asthenia, Hepatic Enzyme Increased, Pruritus
Adverse event was reported on Mar 26, 2008 by a Female taking Delursan (ursodeoxycholic Acid) 250 Mg (Dosage: Oral) . Location: FRANCE , 48 years of age, Directly after, patient experienced the unwanted or unexpected Delursan side effects: asthenia, hepatic enzyme increased, pruritus.
Associated medications used: Patient was hospitalized.

Abdominal Tenderness, Anaemia, Constipation, Faecaloma, Flatulence, Pallor, Peritoneal Effusion, Renal Failure Acute, Small Intestinal Haemorrhage
on Sep 26, 2007 Female from FRANCE , 88 years of age, was diagnosed with and was treated with Delursan (ursodeoxycholic Acid). Patient felt the following Delursan side effects: abdominal tenderness, anaemia, constipation, faecaloma, flatulence, pallor, peritoneal effusion, renal failure acute, small intestinal haemorrhage. Delursan (ursodeoxycholic Acid) dosage: 250 Mg; Oral.
Multiple prescriptions taken:
  • Previscan (fluindione) (Oral)
  • Cordarone (Oral)
  • Deroxat (paroxetine) (Oral)
  • Folic Acid (Oral)
  • Omeprazole (Oral)
  • Primaxin (Oral)
Patient was hospitalized.

Lung Infection Pseudomonal, Oedema Peripheral, Pancytopenia, Pneumonia, Rash, Renal Failure Acute
on Jun 21, 2007 Male from FRANCE , 47 years of age, was treated with Delursan (ursodeoxycholic Acid). After Delursan was administered, patient encountered several Delursan side effects: lung infection pseudomonal, oedema peripheral, pancytopenia, pneumonia, rash, renal failure acute. Delursan (ursodeoxycholic Acid) dosage: 500 Mg Oral.
Multiple concurrent drugs taken:
  • Allopurinol (100 Mg Oral)
  • Certican (everolimus) (1.5 Mg Oral)
  • Cyclosporine (150 Mg Oral)
  • Aspegic (dl-lysine Acetylsalicylate) (100 Mg Oral)
  • Imuran (100 Mg Oral)
Patient was hospitalized.

Hepatic Pain, Jaundice, Transaminases Increased
Patient was taking Delursan (ursodesoxycholic Acid). Directly after, patient experienced the unwanted or unexpected Delursan side effects: hepatic pain, jaundice, transaminases increased on Sep 08, 2006 from FRANCE Additional patient health information: Male , 14 years of age, was diagnosed with and. Delursan (ursodesoxycholic Acid) dosage: 500 Mg Tablets Po. Patient was hospitalized.

Optic Neuritis, Scotoma, Visual Acuity Reduced
Adverse event was reported on May 22, 2006 by a Male taking Delursan (ursodesoxycholic Acid) (Dosage: 1 G Film-coated Tablets Po) was diagnosed with and. Location: FRANCE , 51 years of age, Patient felt the following Delursan side effects: optic neuritis, scotoma, visual acuity reduced.
Multiple prescriptions taken:
  • Methotrexate (10 Mg Po)
  • Remicade (400 Mg Iv)
  • Speciafoldine (folic Acid)
  • Cortan
  • Contramal Lp (tramadol Hydrochloride)
  • Acetaminophen
  • Forlax (macrogol)
  • Lansoprazole
Patient was hospitalized.

Cutaneous Vasculitis, Hepatic Encephalopathy
on Nov 29, 2005 Female from , 62 years of age, was diagnosed with and was treated with Delursan. After Delursan was administered, patient encountered several Delursan side effects: cutaneous vasculitis, hepatic encephalopathy. Delursan dosage: N/A.
Multiple concurrent drugs taken:
  • Lasilix
  • Captopril
  • Lopressor
  • Previscan
  • Sintrom
  • Nph Insulin (Dose: 20 Units On The Morning And 14 Units In The Evening.)
  • Lantus
  • Actrapid (Dose: 4 Units On The Morning And 4units On The Evening.)
Patient was hospitalized.

Cutaneous Vasculitis, Hepatic Encephalopathy
on Nov 28, 2005 Female from FRANCE , 62 years of age, was diagnosed with and was treated with Delursan (ursodesoxycholic Acid). Directly after, patient experienced the unwanted or unexpected Delursan side effects: cutaneous vasculitis, hepatic encephalopathy. Delursan (ursodesoxycholic Acid) dosage: Po.
Associated medications used:
  • Insulin
  • Beta-carotene And Bilberry (difrarel)
  • Duphalac
Patient was hospitalized.

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Delursan

Find Out How to Take Delursan

Discuss Delursan Side Effects

Did You Have a Delursan Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Delursan for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

More About Delursan

Side Effects reported to FDA: 25

Delursan safety alerts: No

Reported deaths: 1

Reported hospitalizations: 5

Latest Delursan clinical trials

Related health facts